Literature DB >> 19212423

Sequential evaluation of prognostic models in the early diagnosis of acute kidney injury in the intensive care unit.

Verônica Torres Costa e Silva1, Isac de Castro, Fernando Liaño, Alfonso Muriel, Jose R Rodríguez-Palomares, Luis Yu.   

Abstract

General and specific severity scores for patients with acute kidney injury have significant limitations due in part to the diversity of methods that have been used. Here we prospectively validated five general (APACHE II, SAPS II, SOFA, LODS, and OSF) and three specific (SHARF, Liaño, and Mehta) scoring systems in 366 critically ill patients who developed acute kidney injury in the intensive care unit. Sequential scores in each system were determined on the day that acute kidney injury was diagnosed, on the day when acute kidney injury-specific score criteria were achieved, and on the day of initial nephrology consultation. Acute kidney injury, defined as an increase of 50% or more in the baseline serum creatinine, was mainly due to sepsis, and had an incidence of 19% and an overall 68% mortality. A progressive improvement in score performance was found. On the day of initial nephrology consultation, most scores showed a good performance and two indices (SAPS II and SHARF) achieved an area under the receiver operating characteristic curve above 0.80. Calibration was good on all three defining days, except for OSF when score criteria were achieved, and Mehta at the time of nephrology consultation. Our study shows that early and sequential evaluation is a better approach for prognostic scoring in critically ill patients who develop acute kidney injury.

Entities:  

Mesh:

Year:  2009        PMID: 19212423     DOI: 10.1038/ki.2009.3

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

1.  Does renal replacement therapy increase mortality in the ICU?

Authors:  David Pestaña
Journal:  Crit Care       Date:  2011-03-24       Impact factor: 9.097

Review 2.  Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury: a critical evaluation of current status.

Authors:  Anja Haase-Fielitz; Michael Haase; Prasad Devarajan
Journal:  Ann Clin Biochem       Date:  2014-02-11       Impact factor: 2.057

3.  Detection of early renal injury in children with solid tumors undergoing chemotherapy by urinary neutrophil gelatinase-associated lipocalin.

Authors:  Mohamed A Almalky; Sheriefa A Hasan; Tamer H Hassan; Doaa A Shahbah; Mohamed A Arafa; Naglaa A Khalifa; Rasha E Ibrahim
Journal:  Mol Clin Oncol       Date:  2015-08-31

Review 4.  Prediction Models and Their External Validation Studies for Mortality of Patients with Acute Kidney Injury: A Systematic Review.

Authors:  Tetsu Ohnuma; Shigehiko Uchino
Journal:  PLoS One       Date:  2017-01-05       Impact factor: 3.240

5.  Construction and Validation of a Risk Prediction Model for Acute Kidney Injury in Patients Suffering from Septic Shock.

Authors:  Suru Yue; Shasha Li; Xueying Huang; Jie Liu; Xuefei Hou; Yufeng Wang; Jiayuan Wu
Journal:  Dis Markers       Date:  2022-01-06       Impact factor: 3.434

Review 6.  Inclusion and definition of acute renal dysfunction in critically ill patients in randomized controlled trials: a systematic review.

Authors:  Rogerio da Hora Passos; Joao Gabriel Rosa Ramos; André Gobatto; Juliana Caldas; Etienne Macedo; Paulo Benigno Batista
Journal:  Crit Care       Date:  2018-04-24       Impact factor: 9.097

7.  Goal-directed therapy in patients with early acute kidney injury: a multicenter randomized controlled trial.

Authors:  Cristina Prata Amendola; João Manoel Silva-Jr; Taisa Carvalho; Luciana Coelho Sanches; Ulysses Vasconcelos de Andrade E Silva; Rosana Almeida; Emmanuel Burdmann; Emerson Lima; Fabiana Ferreira Barbosa; Renata Souza Ferreira; Maria José C Carmona; Luiz Marcelo Sá Malbouisson; Fernando A M Nogueira; José Otavio Costa Auler-Júnior; Suzana Margareth Lobo
Journal:  Clinics (Sao Paulo)       Date:  2018-10-29       Impact factor: 2.365

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.